![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
01 ACTIVE INGREDIENT = 84A ANTIBODY (1)
02 BULK PURIFIED HUMANIZED MONOCLONAL ANTIBODY (AN100226)(NSO CELLS, LONZA) TO ALPHA 4 INTEGRIN (1)
03 BULK PURIFIED HUMANIZED MONOCLONAL ANTIBODY (H5G1-1)(NSO CELLS. LONZA) TO C5 (1)
04 HOST CELL LINE NS0 (1)
05 HOST CELL LINES CHO-K1, CHOK1SV AND CHOK1SV GS-KO (1)
06 HP67.6 ANTIBODY (1)
07 IMMOBILIZED MONOCLONAL ANTIBODY (NK2) TO INTERFERON (1)
08 TOSITUMOMAB [MURINE MONOCLONAL ANTIBODY (B1) AGAINST B LYMPHOCYTES (CD20)] (1)
01 LONZA BIOLOGICS PLC (8)
01 U.S.A (8)
01 Active (2)
02 Inactive (6)
01 Blank (8)